The company
10x Genomics, Inc.
TXG · Nasdaq
TXG stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 59.8% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 52 in a row
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $33.1M
- Officials’ trades on record
- 0
- Institutions holding
- 372 (+60)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Serge SaxonovChief Executive Officer | sold | 1,000at $78.23 | 22 Sep 2026filed 24 Sep 2026 |
| Serge SaxonovChief Executive Officer | sold | 2,000at $79.62 | 22 Sep 2026filed 24 Sep 2026 |
| Serge SaxonovChief Executive Officer | sold | 9,300at $80.90 | 22 Sep 2026filed 24 Sep 2026 |
| Serge SaxonovChief Executive Officer | sold | 9,900at $81.83 | 22 Sep 2026filed 24 Sep 2026 |
| Serge SaxonovChief Executive Officer | sold | 2,800at $82.37 | 22 Sep 2026filed 24 Sep 2026 |
| Shehnaaz SulimanDirector | sold | 292at $78.20 | 22 Sep 2026filed 24 Sep 2026 |
| Shehnaaz SulimanDirector | sold | 614at $79.51 | 22 Sep 2026filed 24 Sep 2026 |
| Shehnaaz SulimanDirector | sold | 1,325at $80.82 | 22 Sep 2026filed 24 Sep 2026 |
| Shehnaaz SulimanDirector | sold | 2,270at $81.67 | 22 Sep 2026filed 24 Sep 2026 |
| Shehnaaz SulimanDirector | sold | 1,222at $82.28 | 22 Sep 2026filed 24 Sep 2026 |
| Adam TaichChief Financial Officer | sold | 1,206at $63.68 | 9 Sep 2026filed 11 Sep 2026 |
| Adam TaichChief Financial Officer | sold | 31,428at $64.31 | 9 Sep 2026filed 11 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCreduced · filed 13 Aug 2026 | 17,629,266$675.9M | -111,706−0.6% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,804,070$414.2M | +724,157+7.2% |
| ARK Investment Management LLCreduced · filed 14 Aug 2026 | 10,003,057$383.5M | -1,714,260−14.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,982,492$267.7M | +69,556+1.0% |
| Quantinno Capital Management LPadded · filed 13 Aug 2026 | 5,469,698$209.7M | +57,937+1.1% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 5,082,594$194.9M | -186,992−3.5% |
| Sumitomo Mitsui Trust Group, Inc.reduced · filed 30 Jul 2026 | 4,194,627$160.8M | -915,587−17.9% |
| Amova Asset Management Americas, Inc.reduced · filed 13 Aug 2026 | 4,192,517$160.7M | -911,661−17.9% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 3,351,911$128.5M | +695,558+26.2% |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 3,148,859$120.7M | -822,941−20.7% |
News
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.